Talphera (TLPH) Other Accumulated Expenses (2011 - 2025)
Talphera's (TLPH) quarterly Other Accumulated Expenses came in at $34000.0 in Q4 2025, down 88.28% year-on-year from $290000.0 in Q4 2024, and down 88.28% quarter-over-quarter from $290000.0 in Q4 2024.
Talphera (TLPH) Other Accumulated Expenses (2011 - 2025) Analysis & Trends
Talphera's Other Accumulated Expenses history runs 13 years deep, the most recent figure standing at $34000.0 for Q4 2025.
- On a quarterly basis, Other Accumulated Expenses fell 88.28% year-over-year to $34000.0 in Q4 2025; TTM through Dec 2025 was $34000.0, a 88.28% decrease from a year earlier, with the FY2025 full-year figure at $34000.0, down 88.28% from the prior year.
- Other Accumulated Expenses eased to $34000.0 in Q4 2025 per TLPH's latest filing, from $290000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.2 million in Q4 2021 and bottomed at $34000.0 in Q4 2025.
- The 5-year median for Other Accumulated Expenses is $319000.0 (2023), against an average of $430400.0.
- Across the five-year window, Other Accumulated Expenses jumped 39.14% in 2021 and sank 88.28% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $1.2 million in 2021, then slumped by 70.58% to $343000.0 in 2022, then slipped by 7.0% to $319000.0 in 2023, then declined by 9.09% to $290000.0 in 2024, then sank by 88.28% to $34000.0 in 2025.
- Per Business Quant, the three latest TLPH Other Accumulated Expenses figures stand at $34000.0 (Q4 2025), $290000.0 (Q4 2024), and $319000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 319,000.00 |
| Dec 31, 2022 | 343,000.00 |
| Dec 31, 2021 | 1.17 Mn |
| Dec 31, 2020 | 838,000.00 |
| Dec 31, 2019 | 980,000.00 |
| Dec 31, 2018 | 695,000.00 |
| Dec 31, 2017 | 842,000.00 |
| Dec 31, 2016 | 821,000.00 |
| Dec 31, 2015 | 808,000.00 |
| Dec 31, 2014 | 615,000.00 |
| Sep 30, 2011 | 103,000.00 |
| Jun 30, 2011 | 151,000.00 |